Director-Affiliated Fund Discloses 9.8% Stake in Mobia Medical Post-IPO, Including $27.5M in IPO Purchases

summarizeSummary

A Schedule 13D filing shows that Longitude Capital, a group including director Patrick G. Enright, now beneficially owns 9.8% of Mobia Medical, Inc. common stock, having invested $27.5 million in the company's recent IPO at $15.00 per share.

check_boxKey Events

• Significant Post-IPO Stake

  Longitude Capital, a group including director Patrick G. Enright, disclosed a 9.8% beneficial ownership stake in Mobia Medical, Inc. following the company's Initial Public Offering on May 11, 2026.

• Substantial IPO Investment

  The Longitude Capital group purchased 1,833,332 shares of common stock in the IPO at $15.00 per share, totaling approximately $27.5 million. This investment was made at a premium to the current market price of $12.11.

• Director Affiliation

  Patrick G. Enright, a member of Mobia Medical's board of directors, is a managing member of the entities within the Longitude Capital group, linking this significant investment directly to company leadership.

• Lock-Up Agreement

  The reporting persons, including the Longitude Capital entities and individuals, have entered into lock-up agreements preventing the sale or transfer of their shares for 180 days following the IPO.

auto_awesomeAnalysis

This Schedule 13D filing reveals that Longitude Capital, a group affiliated with director Patrick G. Enright, has acquired a 9.8% beneficial ownership stake in Mobia Medical following its recent IPO. The group made substantial purchases totaling $27.5 million in the IPO at $15.00 per share. This significant investment by a director-affiliated entity, especially at a price higher than the current market price, signals strong conviction in the company's future prospects shortly after its public debut. The disclosure provides a comprehensive view of the institutional investment by this group, complementing the individual Form 4 filings that reported some of these purchases.